Hutch News

Finding the golden ticket? Cyclin T1 is required for HIV-1 latency reactivation

Finding the golden ticket? Cyclin T1 is required for HIV-1 latency reactivation

From the Emerman lab, Human Biology and Basic Sciences Divisions
Science SpotlightOctober 16, 2023
Hitting ‘undo’ to cure Sickle Cell Disease

Hitting ‘undo’ to cure Sickle Cell Disease

From the Lieber and Kiem Labs, Hematologic Malignancies Program, Cancer Consortium.
Science SpotlightMay 24, 2023
Panning for gold in a dependent-sea of genes

Panning for gold in a dependent-sea of genes

From the Emerman Lab, Human Biology and Basic Sciences Divisions
Science SpotlightMarch 20, 2023
Could gene twins team up against cancer?

Could gene twins team up against cancer?

New approach uncovers gene duplications that could be targets for cancer drugs
Hutch NewsAugust 31, 2021
TOP delivery of CRISPR-Cas9 machinery to primary T cells

TOP delivery of CRISPR-Cas9 machinery to primary T cells

From the Overbaugh Lab, Human Biology Division
Science SpotlightJanuary 18, 2021
Improved CRISPR-Cas9 delivery method allows for fast and precise knockouts

Improved CRISPR-Cas9 delivery method allows for fast and precise knockouts

From the Paddison lab, Human Biology Division
Science SpotlightSeptember 21, 2020
Discovering new strategies used in arms race between bacteria and the viruses that infect them

Discovering new strategies used in arms race between bacteria and the viruses that infect them

Dr. Kevin Forsberg tapped for NIAID New Innovators Award to study arms race between viruses and bacteria
Hutch NewsJune 23, 2020
Catching CRISPR/Cas9 in (Pig Farm)

Catching CRISPR/Cas9 in (Pig Farm)

From the Bradley lab, Basic Sciences and Public Health Sciences Divisions
Science SpotlightFebruary 17, 2020
Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells

Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells

A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
News ReleasesJuly 31, 2019
Improving CRISPR with a heart of gold

Improving CRISPR with a heart of gold

From the Adair Lab, Clinical Research Division
Science SpotlightJuly 15, 2019
Engineering B cells to bypass vaccines

Engineering B cells to bypass vaccines

From the Taylor Lab, Vaccine and Infectious Disease Division
Science SpotlightJuly 15, 2019